231 related articles for article (PubMed ID: 20661651)
1. Lumping of physiologically-based pharmacokinetic models and a mechanistic derivation of classical compartmental models.
Pilari S; Huisinga W
J Pharmacokinet Pharmacodyn; 2010 Aug; 37(4):365-405. PubMed ID: 20661651
[TBL] [Abstract][Full Text] [Related]
2. Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models.
Björkman S
J Pharmacokinet Pharmacodyn; 2003 Aug; 30(4):285-307. PubMed ID: 14650375
[TBL] [Abstract][Full Text] [Related]
3. Automated proper lumping for simplification of linear physiologically based pharmacokinetic systems.
Pan S; Duffull SB
J Pharmacokinet Pharmacodyn; 2019 Aug; 46(4):361-370. PubMed ID: 31227954
[TBL] [Abstract][Full Text] [Related]
4. A compatibility evaluation between the physiologically based pharmacokinetic (PBPK) model and the compartmental PK model using the lumping method with real cases.
Ryu HJ; Kang WH; Kim T; Kim JK; Shin KH; Chae JW; Yun HY
Front Pharmacol; 2022; 13():964049. PubMed ID: 36034786
[TBL] [Abstract][Full Text] [Related]
5. Lumping of whole-body physiologically based pharmacokinetic models.
Nestorov IA; Aarons LJ; Arundel PA; Rowland M
J Pharmacokinet Biopharm; 1998 Feb; 26(1):21-46. PubMed ID: 9773391
[TBL] [Abstract][Full Text] [Related]
6. Physiologically based pharmacokinetics (PBPK).
Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
[TBL] [Abstract][Full Text] [Related]
7. Determination of the Number of Tissue Groups of Kinetically Distinct Transit Time in Whole-Body Physiologically Based Pharmacokinetic (PBPK) Models I: Theoretical Consideration of Bottom-Up Approach of Lumping Tissues in Whole-Body PBPK.
Jeong YS; Kim MS; Chung SJ
AAPS J; 2022 Aug; 24(5):90. PubMed ID: 36002760
[TBL] [Abstract][Full Text] [Related]
8. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.
Jones RD; Jones HM; Rowland M; Gibson CR; Yates JW; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
J Pharm Sci; 2011 Oct; 100(10):4074-89. PubMed ID: 21452299
[TBL] [Abstract][Full Text] [Related]
9. Determination of the Number of Tissue Groups of Kinetically Distinct Transit Time in Whole-Body Physiologically Based Pharmacokinetic (PBPK) Models II: Practical Application of Tissue Lumping Theories for Pharmacokinetics of Various Compounds.
Jeong YS; Kim MS; Chung SJ
AAPS J; 2022 Aug; 24(5):91. PubMed ID: 36002779
[TBL] [Abstract][Full Text] [Related]
10. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.
Poulin P; Jones RD; Jones HM; Gibson CR; Rowland M; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Yates JW
J Pharm Sci; 2011 Oct; 100(10):4127-57. PubMed ID: 21541937
[TBL] [Abstract][Full Text] [Related]
11. Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.
Peters SA; Ungell AL; Dolgos H
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):509-18. PubMed ID: 19562647
[TBL] [Abstract][Full Text] [Related]
12. Utility of a single adjusting compartment: a novel methodology for whole body physiologically-based pharmacokinetic modelling.
Ando H; Izawa S; Hori W; Nakagawa I
Theor Biol Med Model; 2008 Aug; 5():19. PubMed ID: 18687151
[TBL] [Abstract][Full Text] [Related]
13. Lumping in pharmacokinetics.
Brochot C; Tóth J; Bois FY
J Pharmacokinet Pharmacodyn; 2005 Dec; 32(5-6):719-36. PubMed ID: 16341473
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody disposition: a simplified PBPK model and its implications for the derivation and interpretation of classical compartment models.
Fronton L; Pilari S; Huisinga W
J Pharmacokinet Pharmacodyn; 2014 Apr; 41(2):87-107. PubMed ID: 24493102
[TBL] [Abstract][Full Text] [Related]
15. Dose selection based on physiologically based pharmacokinetic (PBPK) approaches.
Jones HM; Mayawala K; Poulin P
AAPS J; 2013 Apr; 15(2):377-87. PubMed ID: 23269526
[TBL] [Abstract][Full Text] [Related]
16. Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modelling.
Jones HM; Gardner IB; Collard WT; Stanley PJ; Oxley P; Hosea NA; Plowchalk D; Gernhardt S; Lin J; Dickins M; Rahavendran SR; Jones BC; Watson KJ; Pertinez H; Kumar V; Cole S
Clin Pharmacokinet; 2011 May; 50(5):331-47. PubMed ID: 21456633
[TBL] [Abstract][Full Text] [Related]
17. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
[TBL] [Abstract][Full Text] [Related]
18. Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data.
Wendling T; Tsamandouras N; Dumitras S; Pigeolet E; Ogungbenro K; Aarons L
AAPS J; 2016 Jan; 18(1):196-209. PubMed ID: 26538125
[TBL] [Abstract][Full Text] [Related]
19. Physiologically based pharmacokinetic tissue compartment model selection in drug development and risk assessment.
Thompson MD; Beard DA
J Pharm Sci; 2012 Jan; 101(1):424-35. PubMed ID: 21968734
[TBL] [Abstract][Full Text] [Related]
20. Modelling and PBPK simulation in drug discovery.
Jones HM; Gardner IB; Watson KJ
AAPS J; 2009 Mar; 11(1):155-66. PubMed ID: 19280352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
